![Samir Gharib](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samir Gharib
Finanzdirektor/CFO bei
SPRUCE BIOSCIENCES, INC.
Vermögen: 446 202 $ am 30.06.2026
Profil
Samir M.
Gharib is currently the Director at Cancer CAREpoint since 2017.
Mr. Gharib is also the President & Chief Financial Officer at Spruce Biosciences, Inc. since 2022.
Formerly, Mr. Gharib was Finance Director & Controller at Talon Therapeutics, Inc. from 2012 to 2013.
Mr. Gharib was Managing Director at Benchmark Financial Partners LLC from 2017 to 2018.
Mr. Gharib was Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017.
Mr. Gharib was Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Education includes an undergraduate degree conferred in 2005 and an MBA from Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC. 0,77 % | 24.03.2026 | 8.263 ( 0,77 % ) | 446 202 $ | 30.06.2026 |
Aktive Positionen von Samir Gharib
| Unternehmen | Position | Beginn |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.05.2020 |
Cancer CAREpoint
 Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Direktor/Vorstandsmitglied | 01.11.2017 |
Ehemalige bekannte Positionen von Samir Gharib
| Unternehmen | Position | Ende |
|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Finanzdirektor/CFO | 01.09.2019 |
Benchmark Financial Partners LLC | Corporate Officer/Principal | 01.10.2018 |
| REVANCE THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.09.2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Finanzdirektor/CFO | 01.09.2013 |
Ausbildung von Samir Gharib
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Cancer CAREpoint
Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Commercial Services |
Benchmark Financial Partners LLC |
